Safety and Efficacy of Lenalidomide in Relapsed or Refractory Multiple Myeloma
Lenalidomide is an oral immunomodulatory drug that has helped improve outcomes in multiple myeloma (MM) patients. Combination lenalidomide and dexamethasone (Len+Dex) has been shown to increase response rates and prolong survival compared with dexamethasone alone in patients with relapsed or refract...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Libertas Academica
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256976/ |